The effect of ciLnidipine On iNtra- and inter- Dialytic blOod pressure in iNtradialytic hypertensive patients: open-label randomized control trial

The effect of ciLnidipine On iNtra- and inter- Dialytic blOod pressure in iNtradialytic hypertensive patients: open-label randomized control trial - LONDON study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013626

Enrollment

Registered

2014-04-04

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hemodialytic patients

Interventions

cilnidipine control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have been on chronic hemodialysis with any causes and are older than 20 years old can be eligible for this study.

Exclusion criteria

Exclusion criteria: Patients who have pre-hemodialysis blood pressure<120 mmHg, symptom of heart failure, ischemic heart disease, malignancy disease, severe heart valve disease, or infectious disease. Patients who can not wear 24 h-ABPM.

Design outcomes

Primary

Measure	Time frame
intradialytic blood pressure elevation during hemodialysis	—

Countries

Japan

Contacts

Public ContactTakayasu Ito

Mie University Graduate School of Medicine Cardiology and Nephrology

takayasu@clin.medic.mie-u.ac.jp+81-59-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026